CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
por THE BAJA POSTNEWSROOMSOURCE: PRN MEDIA CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen …
